126 related articles for article (PubMed ID: 3033893)
1. Mechanism of entry of human rhinovirus 2 into HeLa cells.
Neubauer C; Frasel L; Kuechler E; Blaas D
Virology; 1987 May; 158(1):255-8. PubMed ID: 3033893
[TBL] [Abstract][Full Text] [Related]
2. Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH.
Brabec M; Baravalle G; Blaas D; Fuchs R
J Virol; 2003 May; 77(9):5370-7. PubMed ID: 12692239
[TBL] [Abstract][Full Text] [Related]
3. Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.
Hewat EA; Blaas D
J Virol; 2006 Dec; 80(24):12398-401. PubMed ID: 17005641
[TBL] [Abstract][Full Text] [Related]
4. Uncoating of human rhinovirus serotype 2 from late endosomes.
Prchla E; Kuechler E; Blaas D; Fuchs R
J Virol; 1994 Jun; 68(6):3713-23. PubMed ID: 8189509
[TBL] [Abstract][Full Text] [Related]
5. Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus.
Madshus IH; Olsnes S; Sandvig K
Virology; 1984 Dec; 139(2):346-57. PubMed ID: 6097029
[TBL] [Abstract][Full Text] [Related]
6. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
Hewat EA; Blaas D
J Virol; 2004 Mar; 78(6):2935-42. PubMed ID: 14990711
[TBL] [Abstract][Full Text] [Related]
7. Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2.
Prchla E; Plank C; Wagner E; Blaas D; Fuchs R
J Cell Biol; 1995 Oct; 131(1):111-23. PubMed ID: 7559769
[TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoresis of affinity complexes between subviral 80S particles of human rhinovirus and monoclonal antibody 2G2.
Kremser L; Petsch M; Blaas D; Kenndler E
Electrophoresis; 2006 Jul; 27(13):2630-7. PubMed ID: 16732623
[TBL] [Abstract][Full Text] [Related]
9. Trypsin sensitivity of several human rhinovirus serotypes in their low pH-induced conformation.
Kowalski H; Maurer-Fogy I; Vriend G; Casari G; Beyer A; Blaas D
Virology; 1989 Aug; 171(2):611-4. PubMed ID: 2548332
[TBL] [Abstract][Full Text] [Related]
10. Study of the parameters of binding of R 61837 to human rhinovirus 9 and immunobiochemical evidence of capsid-stabilizing activity of the compound.
Moeremans M; De Raeymaeker M; Daneels G; De Brabander M; Aerts F; Janssen C; Andries K
Antimicrob Agents Chemother; 1992 Feb; 36(2):417-24. PubMed ID: 1318682
[TBL] [Abstract][Full Text] [Related]
11. Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1.
Baravalle G; Brabec M; Snyers L; Blaas D; Fuchs R
J Virol; 2004 Mar; 78(6):2729-37. PubMed ID: 14990693
[TBL] [Abstract][Full Text] [Related]
12. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments.
Brabec M; Blaas D; Fuchs R
Biochem Biophys Res Commun; 2006 Sep; 348(2):741-9. PubMed ID: 16890915
[TBL] [Abstract][Full Text] [Related]
13. Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin.
Pfanzagl B; Andergassen D; Edlmayr J; Niespodziana K; Valenta R; Blaas D
Arch Virol; 2014 Jan; 159(1):125-40. PubMed ID: 23913188
[TBL] [Abstract][Full Text] [Related]
14. Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation.
Ninomiya Y; Ohsawa C; Aoyama M; Umeda I; Suhara Y; Ishitsuka H
Virology; 1984 Apr; 134(2):269-76. PubMed ID: 6100571
[TBL] [Abstract][Full Text] [Related]
15. Human rhinovirus mutants resistant to low pH.
Skern T; Torgersen H; Auer H; Kuechler E; Blaas D
Virology; 1991 Aug; 183(2):757-63. PubMed ID: 1649506
[TBL] [Abstract][Full Text] [Related]
16. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.
Fénéant L; Potel J; François C; Sané F; Douam F; Belouzard S; Calland N; Vausselin T; Rouillé Y; Descamps V; Baumert TF; Duverlie G; Lavillette D; Hober D; Dubuisson J; Wychowski C; Cocquerel L
J Virol; 2015 Aug; 89(16):8346-64. PubMed ID: 26041282
[TBL] [Abstract][Full Text] [Related]
17. Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin.
Bayer N; Prchla E; Schwab M; Blaas D; Fuchs R
FEBS Lett; 1999 Dec; 463(1-2):175-8. PubMed ID: 10601662
[TBL] [Abstract][Full Text] [Related]
18. Human rhinovirus type 16: mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis.
Lee WM; Wang W
J Virol; 2003 Jun; 77(11):6235-44. PubMed ID: 12743280
[TBL] [Abstract][Full Text] [Related]
19. Requirements for entry of poliovirus RNA into cells at low pH.
Madshus IH; Olsnes S; Sandvig K
EMBO J; 1984 Sep; 3(9):1945-50. PubMed ID: 6092049
[TBL] [Abstract][Full Text] [Related]
20. A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid.
Neumann E; Moser R; Snyers L; Blaas D; Hewat EA
J Virol; 2003 Aug; 77(15):8504-11. PubMed ID: 12857919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
